🔎 Trials Near Me

Hem › Crohns sjukdom › Indiana › Indianapolis

Kliniska studier för Crohns sjukdom i Indianapolis, IN

10 studier för Crohns sjukdom söker deltagare vid platser i och runt Indianapolis (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekryterarFas 3
  • Indiana University Health University Hospital ( Site 5022), Indianapolis
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekryterarFas 2
  • Indiana University Health University Hospital /ID# 278129, Indianapolis
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

RekryterarFas 3
  • Riley Hospital for Children, Indianapolis
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2/3
  • IU Health University Hospital, Indianapolis
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekryterarFas 3
  • Indiana University Health University Hospital, Indianapolis
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis
Ålder 2 till 17 · Alla kön · Uppdaterad 23 sep. 2026 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RekryterarFas 3
  • Riley Childrens Hospital, Indianapolis
Ålder 2 till 17 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Indiana University Health Riley Hospital for Children /ID# 262215, Indianapolis
Ålder 2 till 17 · Alla kön · Uppdaterad 24 juni 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekryterarFas 4
  • Riley Hospital for Children at Indiana University Health, Indianapolis
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

RekryterarFas 2/3
  • Riley Hospital for Children, Indianapolis
Ålder 6 till 22 · Alla kön · Uppdaterad 5 maj 2026 · NCT05660746

Crohns sjukdom-studier i andra städer

Andra studier i Indianapolis

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.